Market Cap 40.74M
Revenue (ttm) 11.00M
Net Income (ttm) -69.78M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -634.36%
Debt to Equity Ratio 0.00
Volume 652,000
Avg Vol 781,362
Day's Range N/A - N/A
Shares Out 58.72M
Stochastic %K 70%
Beta 1.03
Analysts Sell
Price Target $10.00

Company Profile

BioAtla, Inc., a clinical-stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. The company's lead clinical stage product candidates include mecbotamab vedotin (BA3011), a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for treating undifferentiated pleomorphic sarcoma and non-small cell lung cancer (NSCLC); and ozuriftabmab vedotin (BA3021), a CAB ADC to treat melanoma and squamous cell carcinoma o...

Industry: Biotechnology
Sector: Healthcare
Phone: 858 558 0708
Fax: 858 558 0709
Address:
11085 Torreyana Road, San Diego, United States
SPYmyQQQ
SPYmyQQQ Oct. 3 at 7:02 PM
🚀 New Signal ✅ 💊 $BCAB 🗓️ Oct 3, 2025 💵 Entry: $0.6779 🎯 Target (Opt.): $0.7318 (+7.95%) 👉 FREE TRIAL! Check bio.
0 · Reply
BiotechValues
BiotechValues Oct. 3 at 2:15 PM
$BCAB if they are smart, they will follow what $PALI did. 1. Announce positive news (partnership and/or positive EpCAM data) 2. stock spikes above $1 to get back into Nasdaq compliance 3. Announce a financing with high quality tutes 4. Stock spikes further 5. comeback begins
2 · Reply
BiotechValues
BiotechValues Oct. 3 at 2:15 PM
$BCAB good to see them getting active for what looks to be a pivotal q4 for them (turnaround story begins). "BioAtla to Present Clinical Data for Mecbotamab Vedotin (BA3011) in Soft Tissue Sarcoma at SITC 2025" https://ir.bioatla.com/news-releases/news-release-details/bioatla-present-clinical-data-mecbotamab-vedotin-ba3011-soft
0 · Reply
shortkiller7
shortkiller7 Oct. 3 at 11:20 AM
$BCAB Jay Long position on $BCAB! Boom up!
0 · Reply
onemillion2012
onemillion2012 Oct. 3 at 5:22 AM
$BCAB very soon.. its time to double up before the stock double.. partnership news very soon now.. Also look at my other looser stocks. $ASMB and the winner of all time shit $BOLT
0 · Reply
shortkiller7
shortkiller7 Oct. 2 at 7:40 PM
$BCAB goal is 4$!
1 · Reply
shortkiller7
shortkiller7 Oct. 1 at 8:34 PM
$BCAB Ready for LO?
0 · Reply
maplelakeduckslayer
maplelakeduckslayer Oct. 1 at 12:35 PM
$BCAB warrants exercisable at 1.19 and the company needs cash bad...not enough money to make it through year end. It pumps to that level will short bigly. If they can't exercise those will be another offering. If it looks like it's gonna pump up to that level may long then go short
2 · Reply
highnihilism
highnihilism Oct. 1 at 10:33 AM
$CMCO Columbus McKinnon Trades: 15 | Total $: 2.6 K | 90D Avg: 13.6 K | Rel. Notional: 0.19 | Call $: 1.5 K | Put $: 1 K | % Single-Leg: 100% | % Multi-Leg: 0% | % Contingent: – $SPRX Spear Alpha ETF Trades: 3 | Total $: 1.5 K | 90D Avg: 12 K | Rel. Notional: 0.13 | Call $: 1.5 K | Put $: 0 | % Single-Leg: 100% | % Multi-Leg: 0% | % Contingent: – $BCAB Bioatla Trades: 15 | Total $: 1.5 K | 90D Avg: 3.2 K | Rel. Notional: 0.47 | Call $: 1.5 K | Put $: 0 | % Single-Leg: 100% | % Multi-Leg: 0% | % Contingent: – $UGP Ultrapar Participacoes Trades: 1 | Total $: 1.5 K | 90D Avg: 4.3 K | Rel. Notional: 0.35 | Call $: 1.5 K | Put $: 0 | % Single-Leg: 100% | % Multi-Leg: 0% | % Contingent: –
0 · Reply
zoonkey
zoonkey Sep. 30 at 3:26 AM
$BCAB CAB BsAb & ADC
0 · Reply
Latest News on BCAB
BioAtla, Inc. (BCAB) Q2 2025 Earnings Call Transcript

Aug 9, 2025, 2:43 AM EDT - 2 months ago

BioAtla, Inc. (BCAB) Q2 2025 Earnings Call Transcript


BioAtla, Inc. (BCAB) Q1 2025 Earnings Call Transcript

May 6, 2025, 5:55 PM EDT - 5 months ago

BioAtla, Inc. (BCAB) Q1 2025 Earnings Call Transcript


BioAtla to Participate in the Citizens Life Sciences Conference

Apr 30, 2025, 8:00 AM EDT - 5 months ago

BioAtla to Participate in the Citizens Life Sciences Conference


BioAtla, Inc. (BCAB) Q4 2024 Earnings Call Transcript

Mar 27, 2025, 6:18 PM EDT - 6 months ago

BioAtla, Inc. (BCAB) Q4 2024 Earnings Call Transcript


BioAtla Cuts 30% of Jobs in Restructuring Effort

Mar 27, 2025, 5:05 PM EDT - 6 months ago

BioAtla Cuts 30% of Jobs in Restructuring Effort


BioAtla, Inc. (BCAB) Q3 2024 Earnings Call Transcript

Nov 9, 2024, 8:53 AM EST - 11 months ago

BioAtla, Inc. (BCAB) Q3 2024 Earnings Call Transcript


BioAtla: Numerous Catalysts Coming In Q4

Oct 7, 2024, 11:29 AM EDT - 1 year ago

BioAtla: Numerous Catalysts Coming In Q4


BioAtla, Inc. (BCAB) Q2 2024 Earnings Call Transcript

Aug 11, 2024, 1:32 AM EDT - 1 year ago

BioAtla, Inc. (BCAB) Q2 2024 Earnings Call Transcript


BioAtla, Inc. (BCAB) Q1 2024 Earnings Call Transcript

May 14, 2024, 8:35 PM EDT - 1 year ago

BioAtla, Inc. (BCAB) Q1 2024 Earnings Call Transcript


BioAtla: A Buried ADC Concern Gets Some New Life In 2024

May 2, 2024, 10:03 AM EDT - 1 year ago

BioAtla: A Buried ADC Concern Gets Some New Life In 2024


BioAtla, Inc. (BCAB) Q4 2023 Earnings Call Transcript

Mar 26, 2024, 7:21 PM EDT - 1 year ago

BioAtla, Inc. (BCAB) Q4 2023 Earnings Call Transcript


SPYmyQQQ
SPYmyQQQ Oct. 3 at 7:02 PM
🚀 New Signal ✅ 💊 $BCAB 🗓️ Oct 3, 2025 💵 Entry: $0.6779 🎯 Target (Opt.): $0.7318 (+7.95%) 👉 FREE TRIAL! Check bio.
0 · Reply
BiotechValues
BiotechValues Oct. 3 at 2:15 PM
$BCAB if they are smart, they will follow what $PALI did. 1. Announce positive news (partnership and/or positive EpCAM data) 2. stock spikes above $1 to get back into Nasdaq compliance 3. Announce a financing with high quality tutes 4. Stock spikes further 5. comeback begins
2 · Reply
BiotechValues
BiotechValues Oct. 3 at 2:15 PM
$BCAB good to see them getting active for what looks to be a pivotal q4 for them (turnaround story begins). "BioAtla to Present Clinical Data for Mecbotamab Vedotin (BA3011) in Soft Tissue Sarcoma at SITC 2025" https://ir.bioatla.com/news-releases/news-release-details/bioatla-present-clinical-data-mecbotamab-vedotin-ba3011-soft
0 · Reply
shortkiller7
shortkiller7 Oct. 3 at 11:20 AM
$BCAB Jay Long position on $BCAB! Boom up!
0 · Reply
onemillion2012
onemillion2012 Oct. 3 at 5:22 AM
$BCAB very soon.. its time to double up before the stock double.. partnership news very soon now.. Also look at my other looser stocks. $ASMB and the winner of all time shit $BOLT
0 · Reply
shortkiller7
shortkiller7 Oct. 2 at 7:40 PM
$BCAB goal is 4$!
1 · Reply
shortkiller7
shortkiller7 Oct. 1 at 8:34 PM
$BCAB Ready for LO?
0 · Reply
maplelakeduckslayer
maplelakeduckslayer Oct. 1 at 12:35 PM
$BCAB warrants exercisable at 1.19 and the company needs cash bad...not enough money to make it through year end. It pumps to that level will short bigly. If they can't exercise those will be another offering. If it looks like it's gonna pump up to that level may long then go short
2 · Reply
highnihilism
highnihilism Oct. 1 at 10:33 AM
$CMCO Columbus McKinnon Trades: 15 | Total $: 2.6 K | 90D Avg: 13.6 K | Rel. Notional: 0.19 | Call $: 1.5 K | Put $: 1 K | % Single-Leg: 100% | % Multi-Leg: 0% | % Contingent: – $SPRX Spear Alpha ETF Trades: 3 | Total $: 1.5 K | 90D Avg: 12 K | Rel. Notional: 0.13 | Call $: 1.5 K | Put $: 0 | % Single-Leg: 100% | % Multi-Leg: 0% | % Contingent: – $BCAB Bioatla Trades: 15 | Total $: 1.5 K | 90D Avg: 3.2 K | Rel. Notional: 0.47 | Call $: 1.5 K | Put $: 0 | % Single-Leg: 100% | % Multi-Leg: 0% | % Contingent: – $UGP Ultrapar Participacoes Trades: 1 | Total $: 1.5 K | 90D Avg: 4.3 K | Rel. Notional: 0.35 | Call $: 1.5 K | Put $: 0 | % Single-Leg: 100% | % Multi-Leg: 0% | % Contingent: –
0 · Reply
zoonkey
zoonkey Sep. 30 at 3:26 AM
$BCAB CAB BsAb & ADC
0 · Reply
dudereally
dudereally Sep. 29 at 11:35 PM
$BCAB man, I wish this turd would get back to$3.00 a share It was a big buyout with another cancer treatment company today. I know I’m being bitter and greedy, but I really wish this company could get out there and get the money they need to start saving people. Cancer sucks. !!!
0 · Reply
Alien1980
Alien1980 Sep. 29 at 1:59 PM
$BCAB trying to breakout above .69 👽👽 $DFLI still holding a few from .3 $NBY on the up and up breaks above 2.5
0 · Reply
miguelgarfer
miguelgarfer Sep. 27 at 7:51 PM
$BCAB Ufff!! Come on. IN few days up 1$.... Start again.
0 · Reply
Bibpoop
Bibpoop Sep. 26 at 10:26 PM
$CYCU folks with the same speculative volume on $BCAB we could reach 3$ ez
0 · Reply
onemillion2012
onemillion2012 Sep. 24 at 3:16 PM
$VNDA sold my vnda and bought more $BCAB
0 · Reply
L2Lurker
L2Lurker Sep. 24 at 2:10 PM
0 · Reply
King_of_Bio
King_of_Bio Sep. 24 at 1:28 PM
$BCAB Too much risk for my wallet but interesting to watch from the sidelines. Seems there's some fight left in it...
0 · Reply
LabPsycho
LabPsycho Sep. 24 at 12:54 PM
$BCAB @BiotechValues IMO, does not rule out a reverse split possibility.
1 · Reply
onemillion2012
onemillion2012 Sep. 24 at 10:28 AM
$BCAB if I buy more. Price goes down. If I sell. Price will triple in weeks. What to do... cry
2 · Reply
zoonkey
zoonkey Sep. 23 at 11:33 PM
$BCAB patience
0 · Reply
dudereally
dudereally Sep. 23 at 8:49 PM
$BCAB I hope they have something solid. Also seems like a good reason to not throw us a bone, knowing that the real deal is coming soon. Hopefully, they’ll put as much in. They can with a nice partnership and then fluff with info on the other partnership. They announced it and haven’t said shit about it. I would assume that if they’ve got money for that project and a partner, that’s helping them develop it they’d be getting somewhere with it ?
0 · Reply
asdfadfsadsafdfassdf
asdfadfsadsafdfassdf Sep. 23 at 5:14 PM
$BCAB bizarre that the company couldn't mention they avoided delisting or put out a press release or anything. Any other company would do this for hype. Makes me think they have something very solid
1 · Reply